GENEVA, Sept. 22 -- OVERLAND THERAPEUTICS (US) INC. (280 Utah Ave., Suite 250South San Francisco, California 94080) filed a patent application (PCT/US2025/020214) for "CHIMERIC ANTIGEN RECEPTORS TARGETING BCMA AND GPRC5D" on Mar 17, 2025. With publication no. WO/2025/194163, the details related to the patent application was published on Sep 18, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LAN, Weijie (c/o Overland Therapeutics (US) Inc.280 Utah Ave., Suite 250South San Francisco, California 94080), CHANG, Chia-Wei (c/o Overland Therapeutics (US) Inc.280 Utah Ave., Suite 250South San Franc...